This month, the Vision Health Advocacy Coalition is pleased to highlight the Autoimmune Association. This group is dedicated to autoimmune disease awareness, advocacy, education and research. Their work brings the health care community one step closer to a world without autoimmune disease. “For over 30 years we have been a pioneer in serving autoimmune patients, sponsoring research and advocating for access to health
This month, the Vision Health Advocacy Coalition is pleased to highlight Prevent Blindness. The group advocates for people living with a wide range of vision and eye health conditions. Prevent Blindness serves patients, caregivers, health care professionals, educators and industry leaders across the country. It advocates at the local, state and national levels for strong public policy and funding for vision and eye
Tennessee and Kentucky are the latest states to enact step therapy reform, joining more than two dozen others in protecting commercially insured patients from the harmful practice. Federal officials, meanwhile, are leaving some seniors vulnerable. Read more on Health Policy Today.
By Paul Phelps, MD, FACS A new drug could restore independence for people with a rare vision condition. For physicians like me, that’s exciting news. Read more on Health Policy Today.
Eye bulging, double vision, watery eyes and debilitating eye pain. Any one of these symptoms is reason to visit an eye doctor, but together they could signify thyroid eye disease. Read more on Health Policy Today.
Injecting a syringe of an unapproved treatment into a patient’s eyeball would be a nightmare scenario for most ophthalmologists. But that is what many major insurance companies are now suggesting doctors do. Read more on Health Policy Today.
By Susan Barajas When you have a disease nobody has heard of, it’s easy to feel alone. And when insurance companies make it harder for you to access treatment, it can become even more disheartening. I know these feelings all too well. Read more on Health Policy Today.
With the nation’s attention riveted on the distribution of COVID-19 vaccines, drugs that allow patients to deal with other serious medical conditions are falling by the wayside. But it doesn’t need to be that way. Read more on Health Policy Today.
From work to school, book clubs to coffee dates, people are online more than ever before. And eye care professionals are bracing for the inevitable impact on vision health. Read more on Health Policy Today.
The disease most likely to lead to blindness remains largely unknown to most Americans, a recent study shows. Read more on Health Policy Today.
